These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4604130)

  • 21. Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon.
    McMillan DE; Wolf PS; Carchman RA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):443-58. PubMed ID: 5481709
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of narcotic analgesic agonists and antagonists on rat brain acetylcholine.
    Domino EF; Wilson A
    J Pharmacol Exp Ther; 1973 Jan; 184(1):18-32. PubMed ID: 4734420
    [No Abstract]   [Full Text] [Related]  

  • 23. Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone.
    Colasanti B; Khazan N
    Neuropharmacology; 1973 Jul; 12(7):619-27. PubMed ID: 4730371
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction of naloxone, nalorphine and pentazocine with narcotic analgesics at the metabolic level].
    Ardentova NN; Bender KI; Panchenko EV; Khokhlova DS
    Farmakol Toksikol; 1981; 44(5):554-8. PubMed ID: 7308434
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro.
    Howes JF; Harris LS; Dewey WL
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):267-76. PubMed ID: 5453231
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on morphine. IX. On the intensity of the abstinence syndrome to morphine induced by daily injections of nalorphine in white mice.
    Huidobro F; Maggiolo C
    Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):97-112. PubMed ID: 5892561
    [No Abstract]   [Full Text] [Related]  

  • 28. Negative reinforcing properties of morphine-antagonists in naive rhesus monkeys.
    Hoffmeister F; Wuttke W
    Psychopharmacologia; 1973; 33(3):247-58. PubMed ID: 4206650
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings].
    Valentino RJ; Herling S; Woods JH
    Psychopharmacol Bull; 1981 Jan; 17(1):51-4. PubMed ID: 7195052
    [No Abstract]   [Full Text] [Related]  

  • 30. Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeys.
    Malis JL; Gluckman MI
    Adv Biochem Psychopharmacol; 1973; 8(0):225-33. PubMed ID: 4211815
    [No Abstract]   [Full Text] [Related]  

  • 31. Some effects of morphine and morphine antagonists on schedule-controlled behavior.
    McMillan DE; Morse WH
    J Pharmacol Exp Ther; 1967 Jul; 157(1):175-84. PubMed ID: 6029483
    [No Abstract]   [Full Text] [Related]  

  • 32. Assays for narcotic antagonist activity in rodents.
    Pierson AK
    Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous quantitative assessment of morphine tolerance and physical dependence.
    Way EL; Loh HH; Shen FH
    J Pharmacol Exp Ther; 1969 May; 167(1):1-8. PubMed ID: 5814495
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (nikethamide); a study using an experimental pain stimulus in man.
    Dundee JW; Gupta PK; Jones CJ
    Br J Pharmacol; 1973 Jun; 48(2):326P. PubMed ID: 4733735
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analgesic properties of narcotic antagonists].
    Rodríguez R
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():207-14. PubMed ID: 4155611
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of writhing by narcotic antagonists.
    Pearl J; Harris LS
    J Pharmacol Exp Ther; 1966 Nov; 154(2):319-23. PubMed ID: 4380744
    [No Abstract]   [Full Text] [Related]  

  • 37. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
    Martin WR; Gorodetzky CW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative studies on the antagonism by naloxone of some narcotic and narcotic-antagonist analgesics.
    Smits SE; Takemori AE
    Br J Pharmacol; 1970 Jul; 39(3):627-38. PubMed ID: 5472208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-dose suppression test in morphine-dependent mice.
    Takemori AE; Stesin AJ; Tulunay FC
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1232-5. PubMed ID: 4406488
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions of narcotic antagonists with receptor sites.
    Goldstein A
    Adv Biochem Psychopharmacol; 1973; 8(0):471-81. PubMed ID: 4212101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.